Restless legs syndrome. A review

Area of Science:

• Neurology
• Sleep Medicine

Background:

• Restless Legs Syndrome (RLS) involves deep-seated, unpleasant leg paresthesias, primarily occurring at rest.
• Symptoms are characteristically relieved by movement, and sleep disturbance is a frequent complication.
• Mild RLS affects up to 5% of the population, with periodic limb movements during sleep often co-occurring.

Purpose of the Study:

• To summarize the key features, common associations, and treatment strategies for Restless Legs Syndrome.
• To highlight the importance of identifying and managing underlying conditions contributing to RLS.
• To outline effective pharmacological interventions for managing severe RLS symptoms.

Main Methods:

• Literature review of RLS characteristics, epidemiology, and associated conditions.
• Analysis of treatment approaches for both idiopathic and secondary RLS.
• Compilation of effective medications for symptomatic relief in severe RLS.

Main Results:

• RLS is idiopathic in most cases but frequently associated with iron deficiency, uremia, pregnancy, diabetes, rheumatoid arthritis, and polyneuropathy.
• Treating the underlying cause is often effective in symptom resolution.
• Pharmacological options for severe RLS include levodopa, bromocriptine mesylate, opioids, carbamazepine, clonazepam, and clonidine hydrochloride.

Conclusions:

• Restless Legs Syndrome is a common condition with significant impact on sleep quality.
• Identifying and addressing secondary causes, such as iron deficiency, is crucial for effective management.
• A range of medications provides symptomatic relief for patients with severe RLS.